Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 17

Results For "RIL"

1436 News Found

Shalby Hospitals gets 5-year kidney transplant approval for Ahmedabad Krishna Unit
Hospitals | April 14, 2026

Shalby Hospitals gets 5-year kidney transplant approval for Ahmedabad Krishna Unit

The license is valid for five years, effective from April 9, 2026


Aragen launches ChemiSHE, India’s first women-led chemistry synthesis lab
R&D | April 14, 2026

Aragen launches ChemiSHE, India’s first women-led chemistry synthesis lab

CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years


Alexion to showcase broad neurology pipeline at AAN 2026 with 20 presentations
R&D | April 14, 2026

Alexion to showcase broad neurology pipeline at AAN 2026 with 20 presentations

The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies


New guidance aims to speed up diagnosis of childhood abdominal cancers
News | April 14, 2026

New guidance aims to speed up diagnosis of childhood abdominal cancers

Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours


India must build its own agile biopharma innovation model: ICMR DG Dr Rajiv Bahl
Policy | April 14, 2026

India must build its own agile biopharma innovation model: ICMR DG Dr Rajiv Bahl

At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace


Briefs: Indoco Remedies and Panacea Biotec
News | April 14, 2026

Briefs: Indoco Remedies and Panacea Biotec

Panacea Biotec receives LoA from CMSS


Gennova CEO Dr Sanjay Singh sees strong innovation momentum for India’s biopharma sector
Biopharma | April 14, 2026

Gennova CEO Dr Sanjay Singh sees strong innovation momentum for India’s biopharma sector

Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics


Roche wins CE mark for blood-based MS brain damage test
News | April 14, 2026

Roche wins CE mark for blood-based MS brain damage test

The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain


Unichem’s US arm recalls Buspirone tablets after stability test OOS result
News | April 13, 2026

Unichem’s US arm recalls Buspirone tablets after stability test OOS result

No adverse events reported; recall involves 5 mg 500-count bottles in the US market


Orbis India Partners Meet 2026 focuses on sustainable, climate-resilient eye care
Hospitals | April 13, 2026

Orbis India Partners Meet 2026 focuses on sustainable, climate-resilient eye care

Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems